Ana Emília Brito

68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis

Cristina Sebastião Matushita, Ana Maria Marques da Silva, Phelipi Nunes Schuck, Matteo Bardisserotto et autres

INTRODUCTION: Prostate cancer (PC) is the second most commonly diagnosed cancer in males. 68Ga-PSMA PET/CT, a non-invasive diagnostic tool to evaluate PC with prostate-specific membrane antigen (PSMA) expression, has emerged as a more accurate alternative to assess disease staging. We aimed to …

br, cn, it (code pays fourni par la source)

Therapy of bone metastases with alpha emitters

Ana Emília Brito, Elba Etchebehere

br (code pays fourni par la source)

Radium-223 as an Approved Modality for Treatment of Bone Metastases

Ana Emília Brito, Elba Etchebehere

br (code pays fourni par la source)

Use of PET/CT to aid clinical decision-making in cases of solitary pulmonary nodule: a probabilistic approach

Felipe Alves Mourato, Ana Emília Brito, Monique Sampaio Cruz Romão, Renata Guerra Galvão Santos et autres

Abstract Objective: To determine the frequency with which 18F-FDG-PET/CT findings change the probability of malignancy classification of solitary pulmonary nodules. Materials and Methods: This was a retrospective analysis of all 18F-FDG-PET/CT examinations performed for the investigation of a solitary pulmonary nodule between …

Use of PET/CT to aid clinical decision-making in cases of solitary pulmonary nodule: a probabilistic approach

Felipe Alves Mourato, Ana Emília Brito, Monique Sampaio Cruz Romão, Renata Guerra Galvão Santos et autres

OBJECTIVE: F-FDG-PET/CT findings change the probability of malignancy classification of solitary pulmonary nodules. MATERIALS AND METHODS: F-FDG-PET/CT examinations performed for the investigation of a solitary pulmonary nodule between May 2016 and May 2017. We reviewed medical records and PET/CT images to collect …

br (code pays fourni par la source)

Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT

Ana Emília Brito, Elba Etchebehere

br (code pays fourni par la source)

Avaliação da carga tumoral de corpo inteiro com PET/CT-PSMA- ⁶⁸GA na recorrência bioquímica do câncer de próstata

Ana Emília Brito

O PET/CT-PSMA- ⁶⁸GA apresenta alta sensibilidade e especificidade na identificação de lesões neoplásicas, especialmente em pacientes com câncer de prostata em recidiva bioquímica. Além de relatar o número e o local destas lesões, a realização deste exame permite a quantificação volumétrica da …

Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT; 4.

Fábio Esteves, Bárbara Juarez Amorim, Milena Martello, Cristina Sebastião Matushita et autres

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize procedures to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized …

us, br (code pays fourni par la source)

Cervical cancer - staging and restaging with 18F-FDG PET/CT

Ana Emília Brito, Cristina Sebastião Matushita, Fábio Esteves, Gustavo do Vale Gomes et autres

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized …

us, br (code pays fourni par la source)

Evaluation of whole-body tumor burden with 68Ga-PSMA PET/CT in the biochemical recurrence of prostate cancer

Ana Emília Brito, Felipe Alves Mourato, R. P. M. de Oliveira, Aline Lopes Garcia Leal et autres

br (code pays fourni par la source)

Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?

Elba Etchebehere, Ana Emília Brito, Kalevi Kairemo, Eric Rohren et autres

Abstract Objective: To determine whether an interim 18F-fluoride positron-emission tomography/computed tomography (PET/CT) study performed after the third cycle of radium-223 dichloride (223RaCl2) therapy is able to identify patients that will not respond to treatment. Materials and Methods: We retrospectively reviewed 34 histologically …

br, us (code pays fourni par la source)

Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?

Elba Etchebehere, Ana Emília Brito, Kalevi Kairemo, Eric Rohren et autres

Abstract Objective: To determine whether an interim 18F-fluoride positron-emission tomography/computed tomography (PET/CT) study performed after the third cycle of radium-223 dichloride (223RaCl2) therapy is able to identify patients that will not respond to treatment. Materials and Methods: We retrospectively reviewed 34 histologically …